TRUMAN MEDICAL CTR LAKEWOOD — History
CCN 260102 | 3-year financial timeline | COVID resilience: 16/100
🛡️ Public data only — no PHI permitted on this instance.
$159M
Latest Revenue (FY2022)
-26.0%
Revenue CAGR (3yr)
-34.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $290M | $178M | $159M | -10.8% | -26.0% |
| Operating Expenses | $206M | $203M | $214M | +5.1% | +2.0% |
| Operating Margin | 29.1% | -14.2% | -34.6% | -143.9% | +0.0% |
| Net Income | $84M | $-25M | $-55M | -117.5% | +0.0% |
| Licensed Beds | 117 | 117 | 117 | +0.0% | +0.0% |
| Total Patient Days | 20,847 | 20,750 | 17,572 | -15.3% | -8.2% |
| Medicare Day % | 14% | 13% | 11% | -14.2% | -10.5% |
| Medicaid Day % | 27% | 32% | 31% | -2.6% | +5.8% |
COVID Impact & Recovery
Resilience Score: 16/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -45.2% ($290M → $159M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-26.0%
This Hospital
+7.6%
State Avg
Latest Margin
-34.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $93M | -66.5% |
| FY2024 (proj) | $28M | -98.4% |
| FY2025 (proj) | $-38M | -130.2% |